About OrthoLogic Research & Development Investors Fact Sheet Stock Information SEC Filings Financial Reports Corporate Governance Corporate Presentation Request Information Press Releases Calendar of Events Quarterly Results Earnings Estimates Analysts Fundamentals Email Alerts
Aug 14, 2008 - OrthoLogic Announces Completion of Dosing for Second AZX100 Phase 1 Human Clinical Trial in Dermal/Hypertrophic Scarring
Aug 12, 2008 - OrthoLogic to Present At Fourth Annual Noble Financial Equity Conference August 19, 2008
Aug 11, 2008 - OrthoLogic Corp. Receives Nasdaq Notice Letter
Aug 7, 2008 - OrthoLogic Announces Chrysalin (TP508) Demonstrates Significant Benefit in a Pre-Clinical Model of Acute Heart Disease
- Past Press Releases
If you have already signed up for OrthoLogic Email Alerts, please enter your email address in the field below and submit. A confirmation email will be sent. Please click on the link provided in the confirmation email to view your alert subscription.
